Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
109 participants
OBSERVATIONAL
2021-04-02
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Appetite Lexicon Training
NCT04576585
Appetite and Adiposity Across a Continuum of Activity
NCT02763449
Effects of Learning and Food Form on Intake in Humans
NCT01490034
Combined Effects of Energy Density and Eating Rate on Appetite
NCT01406886
Effect of Gut-Cued Eating on BMI and Efficacy of Open-Label Placebo to Augment Weight Loss
NCT03850990
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1 weekend day). Participants will be asked to report to the laboratory for instruction on recording appetitive sensations (hunger, fullness, thirst), food intake, physical activity at baseline (week1), week 9, and 17 on 3 days (2 non-consecutive weekdays and 1 weekend day). Ratings of hunger, fullness, and thirst will be recorded on their cell phones/computers via a web-based Qualtrics survey every waking hour for 3 days. All entries are time and date stamped to ensure the ratings are made at the intended times. Participants will be provided hourly alarms to ensure regular recording.
Concurrently, participants will keep a diet record with an ASA-24 system and free-living energy expenditure will be measured using a physical activity tracking application on the same days of appetite ratings.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Young Adult/Normal
Age 18-35, BMI 18.5-24.9
Observational
Observational
Young Adult/Overweight and Obese
Age18-35, BMI greater than 25.0
Observational
Observational
Adult/Normal
Age 36-50, BMI 18.5-24.9
Observational
Observational
Adult/Overweight and Obese
Age 36-50, BMI greater than 25.0
Observational
Observational
Older Adult/Nornal
Age 51-65, BMI 18.5-24.9
Observational
Observational
Older Adult/Overweight and Obese
Age 51-65, BMI greater than 25.0
Observational
Observational
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observational
Observational
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Body weight fluctuation of \<2.5 kg in the past 3 months.
Exclusion Criteria
2. Planning to initiate or terminate medication known to affect appetite.
3. Planning to initiate or terminate lifestyle behaviors that could affect energy balance
4. Age \<18 or \>65 years.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Purdue University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Richard Mattes
Richard Mattes PhD, RD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard D Mattes, PhD
Role: PRINCIPAL_INVESTIGATOR
Purdue University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Purdue Univeristy
West Lafayette, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-1651
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.